WAM
PACB icon

Weiss Asset Management’s Pacific Biosciences PACB Stock Holding History

Weiss Asset Management’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-35,793
Closed -$185K – 370
2019
Q3 		$185K Buy
35,793
+25,700
+255% +$144K 0.01% 257
2019
Q2 		$61K Sell
10,093
-4,263
-30% -$29.9K ﹤0.01% 321
2019
Q1 		$104K Buy
+14,356
New +$104K 0.01% 266

Other funds holding PACB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
WIC
Water Island Capital New York $1.08B AUM 105.75% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Weiss Asset Management's PACB Position: Q4 2019 in Review

Weiss Asset Management sold out of Pacific Biosciences (PACB) in Q4 2019, closing a stake of 35,793 shares — an estimated $185K sold.

Weiss Asset Management first reported a position in PACB in Q1 2019 and held it in 3 quarters. The position peaked at $185K in Q3 2019. 143 funds tracked by Wall St. Rank hold PACB as of Q4 2019.

  • Weiss Asset Management reported no remaining Pacific Biosciences position as of Q4 2019 after selling out during the quarter.
  • Weiss Asset Management sold 35,793 Pacific Biosciences shares in Q4 2019, an estimated $185K.
  • Weiss Asset Management first reported a position in Pacific Biosciences in Q1 2019 and held it in 3 quarters.
  • Weiss Asset Management's Pacific Biosciences position peaked at $185K in Q3 2019.
  • 143 funds tracked by Wall St. Rank held Pacific Biosciences as of Q4 2019.

Based on Weiss Asset Management's 13F filing for Q4 2019, filed 14 Feb 2020.